Reyvow Dosage
Generic name: lasmiditan 50mg
Dosage form: tablet
Drug class: Antimigraine agents
Medically reviewed by Drugs.com. Last updated on Sep 15, 2022.
The recommended dose of REYVOW is 50 mg, 100 mg, or 200 mg taken orally, as needed. No more than one dose should be taken in 24 hours, and REYVOW should not be taken unless the patient can wait at least 8 hours between dosing and driving or operating machinery [see Warnings and Precautions (5.1)].
A second dose of REYVOW has not been shown to be effective for the same migraine attack.
The safety of treating an average of more than 4 migraine attacks in a 30-day period has not been established.
REYVOW may be taken with or without food.
Administer tablets whole; do not split, crush, or chew.
Frequently asked questions
- What are the new drugs for the treatment of migraines?
- Is Reyvow a controlled substance?
- What is Reyvow used for and how does it work?
More about Reyvow (lasmiditan)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (22)
- Drug images
- Side effects
- During pregnancy
- FDA approval history
- Drug class: antimigraine agents
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
